American Herbal Products Association (AHPA) > About Us > Committees > Government Relations Committee

Government Relations Committee

Chairperson: Staci Eisner (Cortex Scientific)
Staff Contact: Michael McGuffin

Committee Purpose: To monitor legislative and regulatory issues and agencies for the purpose of developing industry positions that conform to AHPA's mission.

AHPA Members, if you would like to join this committee, please email the staff contact.

 

Committee Meeting Minutes

March 25, 2020 Meeting Minutes

Meeting of the Government Relations Committee

AHPA Members log in to download the meeting minutes.

March 11, 2020 Meeting Minutes

Meeting of the Government Relations Committee

AHPA Members log in to download the meeting minutes.

November 13, 2019 Meeting Minutes

Meeting of the Government Relations Committee

AHPA Members log in to download the meeting minutes.
RSS
12

Committee-Related News

June 2020 AHPA Report

AHPA Members, Log in to access the AHPA Report

The June 2020 AHPA Report includes snapshots of global COVID-19 responses that impact the international supplement industry, FDA & FTC COVID-19 warning letters target social media and intravenous therapies, RFP for slippery elm  sustainable wild harvest study, updated Hemp-CBD Status Report, and more.

May 2020 AHPA Report & 2019 Annual Report

AHPA Members, Log in to access the AHPA Report

The May 2020 AHPA Report includes the 2019 AHPA Annual Report, the 2020 AHPA Awards, AOAC Official Method of Analysis for cannabinoids in hemp, free cGMP webinars, AHPA advocacy in Oregon, supply chain issues, and more.

Oregon adopts temporary rule prohibiting unsubstantiated claims that goods prevent, treat, diagnose, or mitigate COVID-19 related conditions

AHPA has been working with other trade organizations to seek withdrawal of a much-broader proposed rule that the OR DOJ published for comment late last year and in amended form in March 2020.

The Oregon Department of Justice (OR DOJ) has temporarily adopted a rule declaring it “unfair and deceptive” (and thus unlawful) to represent that any product “will prevent, treat, diagnose, mitigate, or cure coronavirus, COVID-19 or a related condition, without first having competent and reliable scientific evidence upon which to base a reasonable belief in the truth of the representation.” The temporary rule is effective for six months, until October 14, 2020.

AHPA and CRN express concern about Proposed Rule in Oregon that would create private right of action for opportunistic plaintiffs’ lawyers

AHPA and CRN urge that Oregon Proposed Rule is unnecessary and should be withdrawn

AHPA and the Council for Responsible Nutrition (CRN) filed joint comments last week to reiterate significant concerns to the Oregon Department of Justice (OR DOJ) about a Proposed Rule that would create a private right of action for opportunistic plaintiffs' lawyers motivated by the potential for recovery rather than the public interest.

AHPA submits supply chain issues to USDA and continues to collect industry data

Report your supply chain issues to AHPA using this brief survey

AHPA has reported to the U.S. Department of Agriculture (USDA) a host of supply chain issues submitted by members and others in the herbal community. The information submitted to USDA reports on shortages or delivery disruptions of a variety of ingredients, supplies, and services. AHPA also continues to collect supply chain data to inform the industry, regulators and lawmakers.

April 2020 AHPA Report

AHPA Members, Log in to access the AHPA Report

The April 2020 AHPA Report covers COVID-19, including a message from AHPA President Michael McGuffin, free resources and information for the herbal community and a summary of recent federal announcements about FDA inspections and supplement manufacturers and employees being designated as essential.

March 25, 2020 Meeting Minutes

Meeting of the Government Relations Committee

AHPA Members log in to download the meeting minutes.

AHPA joins leading health and food organizations to urge lawmakers to clearly define exemptions to shelter-in-place orders

Three letters urge clear definition of employee exemptions for shelter-in-place orders

In a series of three letters to federal, state, and local governments, AHPA joined healthcare and food organizations to request that uniform language be included in shelter-at-home orders that provide direction to employees working in various industries related to dietary supplements, healthcare, and pharmaceuticals.

AHPA Continuity of Service To Our Members

AHPA services and commitment to shared goals continue during COVID-19 outbreak

As we all try to adapt to rapid changes, please note that the services AHPA provides and the commitment we share with you to our mission to support responsible commerce in herbal products will not change. We are taking precautions in response to this current emergency, so AHPA’s staff are now all working remotely. Each of us can be reached at our normal phone numbers and email addresses (see here).

March 2020 AHPA Report

AHPA Members, Log in to access the AHPA Report

The March 2020 AHPA Report includes a discussion of proposals to make supplement regulation more efficient and effective, the Cannabis Committee's 10-year anniversary, AERs and supplement safety, postponed events and an update on international supplement regulation from IADSA.

RSS
12345678910 Last